Each DSP provides:

• complete understanding of the disease dynamics
• treatment algorithms (based on longitudinal data)
• market definition, labelling, sizing, structure and segmentation
• key drivers for drug therapy
• unmet needs and disease impact
• detailed prescribing patterns (including dosage analysis, switching patterns, combination therapy).
• monitoring brand positioning and performance
• brand mapping
• identification of market trends and changes and
• impact of medico-marketing strategies.

Markets covered include: Europe, USA, Canada, Japan, Latin America and Australia.

Outputs from DSPs are increasingly being used in scientific publications, abstracts, posters, regulatory submissions and detail aids across a number of disease areas to support brand development.

DSP information is also routinely incorporated into health economic and patient-reported outcomes models such as cost of illness and quality of life.

Outcomes Solutions

Real world observational data substantiating opportunities and challenges for brands:

• PROs
• Quality of life
• Patient satisfaction
• Burden of disease
• Resource utilisation
• Longitudinal perspectives
  

Communications Solutions

The industry gold standard for shaping marketing and communication strategy and defining education imperatives

• Tailored consultation and creative input to communications strategy development
• Creative support to key planning meetings
• A statistical service that responds rapidly with expert knowledge of the data
• A writing and publication management service - to secure timely publication
• A creative team delivering campaigns designed to maximise the impact of opinion-changing publications